ES2104889T3 - Derivado de 6-o-metileritromicina a. - Google Patents

Derivado de 6-o-metileritromicina a.

Info

Publication number
ES2104889T3
ES2104889T3 ES92902490T ES92902490T ES2104889T3 ES 2104889 T3 ES2104889 T3 ES 2104889T3 ES 92902490 T ES92902490 T ES 92902490T ES 92902490 T ES92902490 T ES 92902490T ES 2104889 T3 ES2104889 T3 ES 2104889T3
Authority
ES
Spain
Prior art keywords
derivative
activity against
methylerithromycin
bacteria
powerful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92902490T
Other languages
English (en)
Inventor
Masato Raionzugahden Kashimura
Toshifumi Asaka
Shigeo Morimoto
Katsuo Horisakichodan Hatayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2104889T3 publication Critical patent/ES2104889T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN DERIVADO DE 6-O-METILERITROMICINA A REPRESENTADO POR LA FORMULA GENERAL (I) Y LAS SALES FARMACEUTICAMENTE ACEPTABLES DEL MISMO QUE TIENE UNA POTENTE ACTIVIDAD ANTIBACTERIANA CONTRA LA BACTERIA GRAM-NEGATIVA Y UNA ACTIVIDAD AUN MAS POTENTE CONTRA LA BACTERIA GRAM-POSITIVA QUE LA DE LOS COMPUESTOS CONOCIDOS. EN DICHA FORMULA R1 Y R2 REPRESENTAN CADA UNO HIDROGENO O ALQUILO C1 A C3 Y A REPRESENTA NITROGENO O N -> O.
ES92902490T 1990-11-28 1991-11-22 Derivado de 6-o-metileritromicina a. Expired - Lifetime ES2104889T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32652990 1990-11-28

Publications (1)

Publication Number Publication Date
ES2104889T3 true ES2104889T3 (es) 1997-10-16

Family

ID=18188854

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92902490T Expired - Lifetime ES2104889T3 (es) 1990-11-28 1991-11-22 Derivado de 6-o-metileritromicina a.

Country Status (8)

Country Link
US (1) US5403923A (es)
EP (1) EP0559896B1 (es)
KR (1) KR0166096B1 (es)
AT (1) ATE157368T1 (es)
CA (1) CA2096969C (es)
DE (1) DE69127457T2 (es)
ES (1) ES2104889T3 (es)
WO (1) WO1992009614A1 (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631355A (en) * 1992-04-22 1997-05-20 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide a derivatives
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2707088B1 (fr) * 1993-07-02 1995-08-25 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2697523B1 (fr) * 1992-11-05 1994-12-02 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US6274715B1 (en) 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
US5747466A (en) * 1995-11-08 1998-05-05 Abbott Laboratories 3-deoxy-3-descladinose derivatives of erythromycins A and B
ES2218604T3 (es) * 1995-11-08 2004-11-16 Abbott Laboratories Derivados triciclicos de eritromicina.
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
SK285534B6 (sk) * 1996-09-04 2007-03-01 Abbott Laboratories 6-O-substituované ketolidy s antibakteriálnou aktivitou, farmaceutická kompozícia s ich obsahom, ich použitie a spôsob ich prípravy
US5804565A (en) * 1996-09-24 1998-09-08 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
WO1998051696A1 (en) * 1997-05-09 1998-11-19 Pfizer Products Inc. Erythromycin derivatives
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
US6034069A (en) * 1997-09-30 2000-03-07 Abbott Laboratories 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
US6046171A (en) * 1997-10-29 2000-04-04 Abbott Laboratories 6,11-bridged erythromycin derivatives
US6124269A (en) * 1997-10-29 2000-09-26 Abbott Laboratories 2-Halo-6-O-substituted ketolide derivatives
US5955440A (en) * 1998-03-27 1999-09-21 Abbott Laboratories Macrolide LHRH antagonists
US5972898A (en) * 1998-03-27 1999-10-26 Abbott Laboratories 3',3-N-bis-substituted macrolide LHRH antagonists
DK0952157T3 (da) 1998-04-24 2003-10-13 Pfizer Prod Inc 9a, 11b-dehydroderivater af 9-oxim-3-keto-6-0-methylerythromycin
US6387885B1 (en) 1998-08-26 2002-05-14 Abbott Laboratories 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
US6020521A (en) * 1998-08-26 2000-02-01 Abbott Laboratories Macrolide LHRH antagonists
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
US6355620B1 (en) 1999-05-14 2002-03-12 Abbott Laboratories C-2 modified erythromycin derivatives
US6420535B1 (en) 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
US6627743B1 (en) 1999-12-03 2003-09-30 Abbott Laboratories 6-O-methylerythromycin A crystal form III
KR20030011797A (ko) * 2000-03-28 2003-02-11 바이오케미 게젤샤프트 엠베하 맛이 차폐된 과립형 입자
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US6878760B2 (en) * 2001-09-14 2005-04-12 The Goodyear Tire & Rubber Company Preparation of starch reinforced rubber and use thereof in tires
US20030069332A1 (en) * 2001-09-14 2003-04-10 Giorgio Agostini Prepared elastomer/reinforcing filler composite and tire having component thereof
US6838511B2 (en) * 2001-10-11 2005-01-04 The Goodyear Tire & Rubber Company Tire with configured rubber sidewall designed to be ground-contacting reinforced with carbon black, starch and silica
US20030092801A1 (en) * 2001-11-15 2003-05-15 Giorgio Agostini Rubber composition comprised of functionalized elastomer and starch composite with coupling agent and tire having at least one component thereof
US20030096900A1 (en) * 2001-11-16 2003-05-22 Holden Brian David Organic plant derived precipitated silica aggregates, elastomers reinforced therewith and articles such as tires with component thereof
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
US7135573B2 (en) * 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
WO2005070918A1 (en) * 2002-05-13 2005-08-04 Enanta Pharmaceuticals, Inc. Process for the preparation of t-11 bicyclic erythromycin derivatives
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6878691B2 (en) * 2002-05-13 2005-04-12 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US7064110B2 (en) * 2002-05-13 2006-06-20 Enanta Pharmaceuticals, Inc. 6-11 bicycle ketolide derivatives
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6753318B1 (en) * 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
EP1509538A1 (en) * 2002-05-13 2005-03-02 Enanta Pharmaceuticals, Inc. 6,11 bicyclic erythromycin derivatives
US6841664B2 (en) 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US6812216B2 (en) 2002-06-25 2004-11-02 Enanta Pharmaceuticals, Inc. 11-C-substituted derivatives of clarithromycin
US6750204B2 (en) 2002-06-25 2004-06-15 Enanta Pharmaceuticals, Inc. 11-C-substituted ketolides
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) * 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
WO2005030227A1 (en) * 2003-09-23 2005-04-07 Enanta Pharmaceuticals, Inc. 9a, 11-3C-BICYCLIC 9a-AZALIDE DERIVATIVES
US20050145312A1 (en) * 2003-12-18 2005-07-07 Herberger James R.Sr. Tire component, and tire with such component, of rubber composition which contains combination of soybean oil and starch/plasticizer composite
WO2005067919A1 (en) * 2003-12-24 2005-07-28 Enanta Pharmaceuticals, Inc. 11-csubsituted erythromycin derivatives
WO2005067564A2 (en) * 2004-01-07 2005-07-28 Enanta Pharmaceuticals, Inc. 6-11 bicyclic erythromycin derivatives
US7265094B2 (en) * 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
US7419962B2 (en) 2004-12-07 2008-09-02 Enanta Pharmaceuticals, Inc. 3,6-bicyclolides
US7229972B2 (en) 2004-12-07 2007-06-12 Enanta Pharmaceuticals, Inc. 3,6-Bicyclolides
WO2006065721A2 (en) 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. 11, 12-lactone bicyclolides
WO2006065743A2 (en) 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. Tetracylic bicyclolides
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
KR101223158B1 (ko) * 2007-09-17 2013-01-17 이난타 파마슈티칼스, 인코포레이티드 6,11-다리걸친 바이아릴 매크로라이드
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
US4640910A (en) * 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
GB8729369D0 (en) * 1987-12-16 1988-01-27 Beecham Group Plc Chemical compounds
JP2782793B2 (ja) * 1988-06-15 1998-08-06 大正製薬株式会社 エリスロマイシンａ誘導体およびその製造方法

Also Published As

Publication number Publication date
KR0166096B1 (ko) 1999-01-15
ATE157368T1 (de) 1997-09-15
DE69127457T2 (de) 1998-01-22
EP0559896B1 (en) 1997-08-27
DE69127457D1 (en) 1997-10-02
EP0559896A1 (en) 1993-09-15
CA2096969C (en) 2000-11-21
WO1992009614A1 (en) 1992-06-11
EP0559896A4 (en) 1993-10-27
CA2096969A1 (en) 1992-05-29
US5403923A (en) 1995-04-04

Similar Documents

Publication Publication Date Title
ES2146741T3 (es) Derivados de rapamicina utiles como inmunosupresores.
ES2071510T3 (es) Derivados de pirrolidina y de tiazolidina, su preparacion y los medicamentos que les contienen.
ES2062691T3 (es) Derivados hidrogenados de la rapamicina.
CO4290420A1 (es) Derivados antitromboticos de amidinofenilalanina y amidino- piridilalanina
ES472742A1 (es) Procedimiento para la obtencion de derivados de alqueno
MX9602837A (es) Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados.
ES2171416T3 (es) Remedio contra la trombocitopenia.
LU88712I2 (fr) TAXOTERE-Décotaxel
FR2698543B1 (fr) Nouvelles compositions à base de taxoides.
ES2106112T3 (es) Derivados de indano-2-mercaptoacetilamida con una actividad inhibidora de encefalinasa y de ace.
CO4950529A1 (es) Dihidropirimidinas y productos que las contienen
IT7822478A0 (it) Purificazione di una soluzione acquosa di cloruro di sodio.
ES2136103T3 (es) Procedimiento para la preparacion de derivados de estaurosporina.
ES2080900T3 (es) Derivados piranicos utiles como inhibidores de 5-lipoxigenasa.
ES2057959T3 (es) Derivados de tienopiridina y composiciones farmaceuticas que los contienen.
ATE157368T1 (de) 6-0-methylerythromycin a-derivat
ES2095976T3 (es) Compuestos de pirazolopiridina y procedimiento para su preparacion.
ES2039230T3 (es) Procedimiento para preparar antibioticos glicopeptidicos.
CO4520229A1 (es) Derivados de la oxazolidin-2-ona y procedimiento para su obtencion
MX9100225A (es) Derivados del carbostiril
ES2086442T3 (es) Derivados de fluoroetilcamptotecina.
ES2125963T3 (es) Nuevos derivados espiranicos del 3-amino-cromano, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
ITMI920084A0 (it) Alchil derivati del trazodone
ES2189736T3 (es) Derivados de la benzamida y medicamentos que los contienen.
NO941084D0 (no) Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 559896

Country of ref document: ES